Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Gastroenterology|September 28, 2014
Systemic treatmentMaria Reig, Alessia Gazzola, Roberto Di Donato, et al.
Digestive Diseases (Basel, Switzerland)|July 11, 2015
Systemic Treatment: Expecting Further SuccessAlessia Gazzola, Maria Reig, Roberto Di Donato, et al.
Digestive Diseases (Basel, Switzerland)|June 23, 2012
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challengesAnna Giacomin, Adriana Sergio, Veronica Vanin, et al.
European Journal of Gastroenterology & Hepatology|May 13, 2025
Impact of multidisciplinary discussion on pancreatic neuroendocrine tumours, experience of a tertiary centreFrancesca Lodato, Alessia Gazzola, Marco Signoretti, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Clinical Endoscopy|February 26, 2025
Impact of contrast dye submucosal pre-lifting on cold snare resection of small polyps: an Italian randomized observational trialRamona Schiumerini, Paola Baccarini, Adele Fornelli, et al.
Journal of Clinical Medicine|May 13, 2023
The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access SystemLiza Ceroni, Francesca Lodato, Paolo Tubertini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2017
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard TherapyStuart K Roberts, Ricky Lim, Simone Strasser, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Pageof 1